Alaska Air Group projects its Q2 2026 revenue to grow 10.5% year-over-year to $4.09 billion, driven by strong passenger demand and stabilized domestic travel. Despite this revenue increase, analysts expect the company to report an EPS loss of approximately -$0.97, a sharp decline from a $1.78 profit in the same quarter last year. However, recent analyst revisions have raised the EPS estimate by 76.1%, indicating a somewhat improved short-term outlook despite ongoing economic challenges like inflation. The earnings report, due July 21 after market close, will be closely watched for insights into Alaska Air's financial health amid changing market conditions.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
